Cargando…

IL-33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation

Regulatory T cells (Tregs) are crucial mediators of immune homeostasis with the ability to modulate allogeneic response and control transplant rejection. Although Treg-based cell therapies have shown immense promise, methods to optimize current strategies are critical for successful implementation w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawai, Kento, Uchiyama, Masateru, Hester, Joanna, Issa, Fadi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613121/ https://www.ncbi.nlm.nih.gov/pubmed/33314772 http://dx.doi.org/10.1111/ajt.16266

Ejemplares similares

Homing of Regulatory T Cells to Human Skin Is Important for the Prevention of Alloimmune-Mediated Pathology in an In Vivo Cellular Therapy Model
por: Issa, Fadi, et al.
Publicado: (2012)

Development of LT-HSC-Reconstituted Non-Irradiated NBSGW Mice for the Study of Human Hematopoiesis In Vivo
por: Adigbli, George, et al.
Publicado: (2021)

IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection
por: Popovic, Branka, et al.
Publicado: (2017)

Regulatory T-cell therapy approaches
por: McCallion, Oliver, et al.
Publicado: (2022)

Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage in vivo
por: Issa, Fadi, et al.
Publicado: (2019)

Chimeric antigen receptor‐modified human regulatory T cells that constitutively express IL‐10 maintain their phenotype and are potently suppressive
por: Mohseni, Yasmin R., et al.
Publicado: (2021)

Systemic silencing of Phd2 causes reversible immune regulatory dysfunction
por: Yamamoto, Atsushi, et al.
Publicado: (2019)

Graft protective effect and induction of CD4(+)Foxp3(+) cell by Thrombomodulin on allograft arteriosclerosis in mice
por: Yin, Enzhi, et al.
Publicado: (2018)

The Role of IL-33 in Experimental Heart Transplantation
por: Chen, Jie, et al.
Publicado: (2020)

IL-33 Drives Augmented Responses to Ozone in Obese Mice
por: Mathews, Joel A., et al.
Publicado: (2016)

IL-33 and IL-37: A Possible Axis in Skin and Allergic Diseases
por: Borgia, Francesco, et al.
Publicado: (2022)

IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut()
por: Sattler, Susanne, et al.
Publicado: (2014)

The Alarmin IL-33 Promotes Regulatory T Cell Function in the Intestine
por: Schiering, Chris, et al.
Publicado: (2014)

NUCLEAR DEFECTIVE IL-33 DRIVES AN ANTI-TUMORIGENIC MICROENVIRONMENT IN GLIOBLASTOMA
por: Menon, Shyam V, et al.
Publicado: (2023)

Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease, and Regenerative Medicine
por: Adigbli, George, et al.
Publicado: (2020)

Freezing Medium Containing 5% DMSO Enhances the Cell Viability and Recovery Rate After Cryopreservation of Regulatory T Cell Products ex vivo and in vivo
por: Kaiser, Daniel, et al.
Publicado: (2021)

Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
por: Stark, Helen L., et al.
Publicado: (2021)

Ex vivo-expanded human CD19(+)TIM-1(+) regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis
por: Shankar, S., et al.
Publicado: (2022)

Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation
por: Takatori, Hiroaki, et al.
Publicado: (2018)

IL-33 Drives Expansion of Type 2 Innate Lymphoid Cells and Regulatory T Cells and Protects Mice From Severe, Acute Colitis
por: Ngo Thi Phuong, Nhi, et al.
Publicado: (2021)

IL-33 Drives Monocyte Recruitment to Lung Interstitium through Chemokine Upregulation
por: Tjota, Melissa Y., et al.
Publicado: (2017)

PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions
por: Ercolano, Giuseppe, et al.
Publicado: (2021)

IL-1β Suppresses Innate IL-25 and IL-33 Production and Maintains Helminth Chronicity
por: Zaiss, Mario M., et al.
Publicado: (2013)

IL-33 induces NF-κB activation in ILC2 that can be suppressed by in vivo and ex vivo 17β-estradiol
por: Trivedi, Shubhanshi, et al.
Publicado: (2022)

Critical roles of interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) in pulmonary disorders
por: Xu, Jiao, et al.
Publicado: (2022)

Adipose-mesenchymal stromal cells suppress experimental Sjögren syndrome by IL-33-driven expansion of ST2(+) regulatory T cells
por: Liu, Ousheng, et al.
Publicado: (2021)

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
por: Brook, Matthew Oliver, et al.
Publicado: (2022)

Tristetraprolin inhibits gastric cancer progression through suppression of IL-33
por: Deng, Kaiyuan, et al.
Publicado: (2016)

Interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) axis in idiopathic inflammatory myopathies and its association with laboratory and clinical parameters: a pilot study
por: Opinc, Aleksandra, et al.
Publicado: (2020)

Alternaria-derived serine protease activity drives IL-33–mediated asthma exacerbations
por: Snelgrove, Robert J., et al.
Publicado: (2014)

Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients
por: Bottomley, Matthew J., et al.
Publicado: (2022)

A complicated liaison: IL-33 and IL-33R in arthritis pathogenesis
por: Kamradt, Thomas, et al.
Publicado: (2013)

Regulatory Mechanism of the IL-33–IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
por: Tsuji, Gaku, et al.
Publicado: (2023)

Regulatory Role of Zinc in Allergic Rhinitis through the IL-33/ST2 Pathway
por: Wen, Wulin, et al.
Publicado: (2022)

Barriers to Treg therapy in Europe: From production to regulation
por: Hennessy, Conor, et al.
Publicado: (2023)

IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGFβ Release
por: Siede, Julia, et al.
Publicado: (2016)

The ST2/IL-33 Pathway in Adult and Paediatric Heart Disease and Transplantation
por: Brunetti, Giacomina, et al.
Publicado: (2023)

Low-Dose Rapamycin Treatment Increases the Ability of Human Regulatory T Cells to Inhibit Transplant Arteriosclerosis In Vivo
por: Hester, J, et al.
Publicado: (2012)

Editorial: Regulatory T Cells
por: Issa, Fadi, et al.
Publicado: (2022)

IL-33/IL-31 Axis in Osteoporosis
por: De Martinis, Massimo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8bcgnt2q9cilptr8dcdl49lgcp